5HT1レセプターアゴニストを含む医薬組成物

Title:

5HT1レセプターアゴニストを含む医薬組成物

Document Type and Number:

Japanese Patent JP3699969

Kind Code:

B2

Abstract:

The present invention relates to a pharmaceutical composition for oral administration capable of rapid disintegration and dispersion within the gastrointestinal tract comprising sumatriptan or a pharmaceutically acceptable salt or solvate thereof as active ingredient, in particular a composition in solid-dosage form that is intended to be swallowed, and methods of treatment of cephalic pain, especially migraine, using such composition.

More Like This:

JP4928794	Lubricating agent for tablets, manufacturing method of tablets and tablets
JP5620391	Pharmaceutical combination containing lipoic acid and hydroxycitric acid as active ingredients
JP2000507218	[Title of the Invention] An implant that releases a drug substance in stages

Inventors:

Robert William Baker
Alan David Dow
Simon John Summers
Julian Westlap

Application Number:

JP2003548808A

Publication Date:

September 28, 2005

Filing Date:

December 04, 2002

Export Citation:

Click for automatic bibliography generation Help

Assignee:

GLAXO GROUP LIMITED

International Classes:

A61K9/20; A61K9/22; A61K9/28; A61K9/46; A61K31/00; A61K31/40; A61K31/404; A61K31/4045; A61K31/4172; A61K47/04; A61K47/38; A61P25/04; A61P25/06; A61P43/00; (IPC1-7): A61K31/4045; A61K9/28; A61K9/46; A61P25/06

Domestic Patent References:

JP6505020A
JP6503826A
JP60193916A
JP5157813A
JP2002543109A

Foreign References:

US4289751

Attorney, Agent or Firm:

Mitsuo Tanaka
Michiko Matsutani
Tadayuki Motoyama
Kenji Tomita
Mina Shiga

Previous Patent: MULTIPLEX SYNCHRONIZATION RF COIL

Next Patent: WEAR DETECTING DEVICE FOR MOTOR BEARING